The award of the top personality award in the Greek industry Industry In the last 30 years, it was held in a climate of recognition and respect for the late Pavlos Giannakopoulosin the context of the 4th Reputation Pharma Conference. The conference ended on Wednesday, April 2, 2025 at Divani Caravel and was organized by the Institute of Health Policy and Reputation Unique, with the aim of examining the image and reputation of the pharmaceutical industry in Greece.
On the occasion of the award, which is the result of original reputation research among executives in the pharmaceutical industry, President & CEO of VIANEX, Mr. Dimitris Giannakopoulos, said: “Every award of my late father is a deeply moving moment. Today, I feel particularly proud, as its name is spontaneously recognized as a leading personality of the Greek pharmaceutical industry. Pavlos Giannakopoulos created VIANEX, building trusting relationships and investing in high know -how. He taught us how to overcome the “weak” and move forward with moral and social responsibility. VIANEX’s award for her social footprint is a tribute to his legacy. “
Vice President of VIANEX Mr. Konstantinos Panagoulias made a special mention to the late founder of Pavlos Giannakopoulos, emphasizing his timeless influence on the Greek pharmaceutical industry, as well as his pioneering, insightful thought and integrity.
At the same time, VIANEX won the Hellenic Pharmaceutical Society Image & Reputation Award in the category of social footprint, once again confirming the company’s constant effort for quality and contribution to the community.
During the conference, Mr. Panagoulias participated in a particularly interesting discussion on “Winning a reputation from innovation, investment and CSR”. In his placement, he referred to the group’s differentiated portfolio of products, which allows communication with both the medical and pharmaceutical community and the general public through MISYFA ads. In addition, he highlighted the significant volume of medicinal products produced or traded by the group, reaching 15% of the market. Finally, he announced the forthcoming launch of the new Research Center in Patras and confirmed the continued social contribution of VIANEX through the Pavlos Giannakopoulos Foundation.
The 4th Reputation Pharma Congress highlighted, for another year, the decisive role of image and reputation in the pharmaceutical industry, underlining the importance of credibility, innovation and responsible entrepreneurship.